Inhibited growth of colon cancer carcinomatosis by antibodies to ...

First-in-human trial of multikinase VEGF inhibitor regorafenib and ...

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer.

Treatment Clinical Trials for Colon Cancer - NCI

Chemotherapy drugs, such as leucovorin, fluorouracil, and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

Neutrophil extracellular traps promote peritoneal metastasis of colon ...

In order to define the role of neutrophils in peritoneal spread of colon cancer cells, mice were made neutropenic by use of a specific antibody ...

Treatment of Metastatic Colorectal Cancer: ASCO Guideline

Anti–epidermal growth factor receptor (EGFR) therapy plus doublet chemotherapy should be offered as first-line therapy to patients with MSS or ...

Prioritization of EGFR/IGF-IR/VEGFR2 Combination Targeted ...

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Brit J Cancer 85: 584-589, 2001.

Peritoneal Cancer Clinical Trials - Mayo Clinic Research

Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

L2pB1 Cells Contribute to Tumor Growth Inhibition - Frontiers

Similar effects were observed in an MC38 murine colon cancer model. Moreover, our data suggest that one of the ways that L2pB1 cells can induce ...

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer.

STING activation normalizes the intraperitoneal vascular-immune ...

Background Peritoneal carcinomatosis is a fatal clinical presentation of colon cancer, characterized by unresponsiveness to conventional anticancer ...

EGFR signaling in colorectal cancer: a clinical perspective | GICTT

Main efforts, focused on the epidermal growth-factor receptor (EGFR), which plays a pivotal role in CRC pathogenesis, have led to the ...

Cancer research - VIVO

Exogenous and Endogenous Sources of Serine Contribute to Colon Cancer Metabolism, Growth, and Resistance to 5-Fluorouracil.. 81. 2021; Induction of ADAM10 by ...

The Antitumor and Antiangiogenic Activity of Vascular Endothelial ...

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors · Medicine, Biology. British Journal ...

Unleashing the power of anti-HER2 therapies in metastatic ...

... anti–epidermal growth factor receptor antibody therapy in metastatic colorectal cancer. JCO Precis Oncol. 2019; 3:1-13. Crossref · Scopus (70).

Malignant ascites: Current therapy options and treatment prospects

This may be caused by tumor growth into the portal vein, constriction due to tumor mass effects or thrombosis of the portal vein, which can ...

An Interleukin 2/Sodium Butyrate Combination as Immunotherapy ...

We tried to do so by modifying the phenotype of the weakly immunogenic rat colon cancer PROb cells with sodium butyrate. Methods:After in vitro treatment with ...

Noninternalizing Monoclonal Antibodies Are Suitable Candidates for ...

The internalizing m225 mAbs had a strong inhibitory effect on tumor growth both in the unlabeled and in the labeled forms (Fig. 2B). Indeed, mean tumor weight ...

Cancer immunotherapy with STING agonist and PD-1 immune ...

Methods: C57Bl6/ mice were intraperitoneally implanted with MC38 colon cancer cells to develop peritoneal carcinomatosis with malignant ascites. Tumor-bearing ...

targeted treatment for advanced colorectal carcinoma

cular endothelial growth factor (anti-VEGF) antibody, cetuximab ... Inhibited growth of colon cancer carcinomatosis by antibodies to ...

Immune Effects of M51R Vesicular Stomatitis Virus Treatment of ...

Immune Effects of M51R Vesicular Stomatitis Virus Treatment of Carcinomatosis From Colon Cancer ... We found that M51R VSV inhibited the growth ...

Peritoneal carcinomatosis of colorectal cancer is characterized by ...

Citation To identify cytokines potentially influencing cancer cell division rates, human samples of PC and pCRC were stained for IFNγ, IL-17A and forkhead box ...